Netherlands: Daily Stock Market Performance Insight - January 13, 2026

Van Lanschot Kempen navigates difficult waters with a 6-day decline (55.10 → 52.90), down 4.0%. Weak margins on 131.6M revenue with only 17.5M profit (13.3% margin) in Qtr ending Jun 2016 validate market skepticism. Structural improvements needed before sentiment shifts.

Eurocommercial pulls back after a 4-day decline (27.05 → 25.75), down 4.8%. However, fundamentals remain robust: 66.4M revenue generating 35.6M profit (53.6% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

NewAmsterdam Pharma takes a breather following a 3-day decline (36.61 → 31.86), down 13.0%. Financial struggles compound the decline: despite 3.0M revenue, - 39.5M losses persist (-1327.3% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

Envipco Holding N.V takes a breather following a 3-day decline (5.10 → 4.74), down 7.1%. Financial struggles compound the decline: despite 23.1M revenue, - 2.5M losses persist (-10.9% margin) as of Qtr ending Jun 2025. Until profitability improves, caution remains warranted.

Uniqure N.V consolidates with a 2-day decline (25.09 → 21.50), down 14.3%. Financial struggles compound the decline: despite 3.7M revenue, - 80.5M losses persist (-2175.9% margin) as of Qtr ending Sep 2025. Until profitability improves, caution remains warranted.

Pharming Group N.V consolidates with a 1-day decline (18.17 → 18.02), down 0.8%. Weak margins on 97.3M revenue with only 7.5M profit (7.8% margin) in Qtr ending Sep 2025 validate market skepticism. Structural improvements needed before sentiment shifts.